David M. Burd
July 4, 2011

inserted for testing

Industrialized nations around the globe have brought their AIDS deaths toward vanishing with many down to double or single digits, the exception being the United States staying near 16,000 annual deaths since 2000. During this time, the U.S. mainstream media has suppressed news of dramatic victory everywhere over AIDS, thus both shielding failure by U.S. health leaders from scrutiny, and allowing specious justifications for record breaking funding.

Comparing apples to apples, the latest annual AIDS deaths for nations having modern sewerage, clean water, and medical care are a revelation: Canada with but 43 deaths, Germany 73, Australia 47, Sweden 10, Denmark 14, and Ireland 3. Other nations such as France and UK have close to 300 deaths but it is important to note the greater bulk of these are from health compromised sub–Saharan immigrants.

The U.S. AIDS death rate (per population) is 20 to 60 times the above gross numbers, yet the chasm widens when subtracting sub–Saharan immigrants from the respective nations, bringing the U.S. death rate 40 to 100 times higher.

The Congress, the President, and public are unaware of this victory over AIDS as mainstream media plays lapdog to American health leaders. These leaders are undoubtedly aware of the rest of the world but keep it to themselves while issuing press releases about antiviral drugs for Africa, and absurd studies about preemptive–HIV pills for the sexually active. Thus, the NIH and CDC keep growing their stupendous AIDS empires, empires that would vanish overnight if their leaders honestly reviewed their own failed orthodoxy.

The perpetual U.S. AIDS catastrophe rests on a medical definition invented 18 years ago in 1993, a unique definition of AIDS used solely in the U.S. and consisting of but two criteria:

1. An arbitrarily set low white cell (CD4) count.
2. A positive HIV–antibody test.

By year 2000 this AIDS category accounted for 90% of new AIDS U.S. cases in the U.S., in 2011 estimated up to 96%. The consequences are huge: Any American so diagnosed with AIDS can go to Canada (or any another country) for a second opinion, and 24 out of 25 times would not get an AIDS diagnosis, not be psychologically traumatized, and not urged on inappropriate toxic drugs.

That antiviral drugs can be lethal is well known, but the panic of the mid–1980’s quashed all caution and ushered in a drug called AZT (short for azidothymidine) invented in 1961 to kill human cells for cancer experimentation. However, with caution abandoned, in 1985 AZT was used on hundreds of HIV+ subjects at the National Cancer Institute, Bethesda, Maryland. Those staying on the drug all died, with their drug–associated deaths blamed not on the deadly drug but on HIV, spurring the panic

Failing to understand AZT’s lethality and after a further controversial NIH Trial, AZT was FDA approved and urged on all AIDS patients in early 1987. But right away prescriptions expanded into the general population, as FDA rules allow, with bewildered monogamous spouses, virgins, and thousands of healthy others merely HIV+ and having (or not having) low CD4 counts urged onto AZT. Then, in 1990, after those HIV+ with a CD4 count of 500 were swept into the AZT–candidate pool, annual American deaths attributed to HIV swiftly escalated to 50,000. During this rising carnage, a cowering public and Congress were told AZT was “extending the quality of life” – the exact opposite of reality.

In 1996, Americans were switched to a new regimen of AZT and protease inhibitors called HAART, to be taken daily by everybody merely HIV+. Tellingly, however, other nations became more and more cautious about employing strong antiviral regimens, and consequently their death tolls began sliding down to the numbers mentioned above as those newly diagnosed HIV+ escaped organ destruction from prior regimens, and because a greater percentage refused or quickly dropped any antiviral treatment.

In 2006 when patents for AZT expired, NIH leaders dropped HAART and promoted a new patented pill combining three antiviral drugs, their rationale being less side effects. Now, five years later with negligible change in AIDS deaths, this “3 in 1” pill funded at $14,000 per year per patient costs taxpayers $9.8 billion a year. Though many quit this pill due to its side effects, HIV testing rotates in an endless supply of healthy Americans to soon spiral downward after “taking their medicine.”

Conclusion: Congress, kept ignorant by CDC and NIH leaders and a complicit media, has been lavishing 3/4 of one per cent of the entire Federal Budget on an historic blunder based on a rogue definition of AIDS invented by these same leaders, resulting in massive death of Americans directly caused by drugs promoted by these leaders who have forgotten the fundamental medical tenet “First, do no harm.”

Since 2001, Congress has spent an astronomical $225 billion on AIDS, $27.2 billion just for 2011. Yet American deaths stay around 16,000 a year, a rate hundred times other nations employing basic treatments for specific diseases, and who have long conquered AIDS. An enlightened Congress must end this man–made blunder by terminating funding, and sack, further hold accountable those responsible. Meanwhile, to save their lives, Americans need only travel to Canada for a second opinion.

David M. Burd, Medical Technology Consultant, Alexandria, Virginia.

References:

1. Debating AZT, Mbeki and the AIDS Drug Controversy; Anthony Brink, Open Books, Politics/medicine/health, ISBN 0 620 26177 3.
2. Federal Initiative to Address HIV/AIDS in Canada, 2010.
3. European Centre for Disease Prevention and Control, HIV/AIDS Surveillance in Europe 2009.
4. Sexually transmitted infections/HIV/AIDS programme. WHO/Europe survey on HIV/AIDS and antiretroviral therapy: 31 Dec. 2006.
5. HIV and AIDS in Canada, Surveillance Report to 31 December, 2009, Public Health Agency of Canada.
6. U.S. Federal Funding for HIV/AIDS: The FY 2011 Budget; Henry J. Kaiser Family Foundation.
7. The United States CDC, AIDS Statistics, 2000–2009.
8. The Annals of Internal Medicine, 16 Jan. 2007, Vol. 146, Issue 2, Pages 87–98: Survival of Persons with and without HIV Infection in Denmark, 1995–2005.
9. Journal of Acquired Immune Deficiency Syndromes, 2000; 24:154–161. Effect of Prenatal Zidovudine on Disease Progression in Perinatally HIV–1 Infected Infants.
10. Journal of Biosciences, Vol. 28, No. 4, June 2003; 383–412. The chemical bases of the various AIDS epidemics: recreational drugs, anti–viral chemotherapy and malnutrition.
11. AIDS Surveillance Update in NYC. 4th Quarter 2000; Figure 1. Adult/Adolescent AIDS Cases By Case Definition and Year of Diagnosis.

Copyright 2011 by the Alberta Reappraising AIDS Society.